IP Verse

Intercept Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Intercept Pharmaceuticals opposed by its competitors

Explore Intercept Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3352768
Nov 2, 2022Methods Of Promoting Hepatic Regeneration4
EP3253382
Nov 17, 2021Pharmaceutical Compositions For Combination Therapy1
EP3437645
Sep 22, 2021Film-Coated Tablet Having High Chemical Stability Of Active Ingredient1

Latest publications and patents of Intercept Pharmaceuticals New

Explore the latest publications and patents granted to Intercept Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 17, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Intercept Pharmaceuticals

EP3352768
Nov 2, 2022Methods Of Promoting Hepatic RegenerationRevoked
EP3253382
Nov 17, 2021Pharmaceutical Compositions For Combination TherapyRevoked
EP3437645
Sep 22, 2021Film-Coated Tablet Having High Chemical Stability Of Active IngredientRevoked

Latest PTAB cases involving Intercept Pharmaceuticals

Discover the latest PTAB cases involving Intercept Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Intercept Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INTERCEPT PHARMACEUTICALS - 6 - -
HAMM & WITTKOPP112 - - -
SANDOZ1171619 -
STADA ARZNEIMITTEL10928 - -